Healthcare
KLRA
Kailera Therapeutics, Inc.
$16.21-12.52%
Add to Watchlist
Loading chart...
About Kailera Therapeutics, Inc.
Kailera Therapeutics is a drug development company working on treatments for obesity. The company is still in early testing stages and is developing drugs in three forms: shots you inject, pills you swallow, and a combination injectable. Its main experimental drugs are designed to work on receptors in the body that control appetite and metabolism. The company was founded in 2024 and is based in Massachusetts.
Full research is for ConvictionStocks members
Get Full AccessAnalyst Coverage
Full research is for ConvictionStocks members
Get Full AccessRecent News
Full research is for ConvictionStocks members
Get Full AccessGet the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Related Research
More Healthcare stocks to explore